Neuroprotection for traumatic brain injury

Handbook of Clinical Neurology

Volumn 127, Issue , 2015, Pages 343-366

  Loane, David J ^a   Stoica, Bogdan A ^a   Faden, Alan I ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Cell death mechanisms; Inflammation; Multipotential drugs; Neuroprotection; Traumatic brain injury

Indexed keywords

NEUROPROTECTIVE AGENT;

ANIMAL; BRAIN INJURIES; HUMAN;

ANIMALS; BRAIN INJURIES; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 84924981385     PISSN: 00729752     EISSN: 22124152     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52892-6.00022-2     Document Type: Chapter

References (250)

1. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat Rev Immunol 2005, 5:629-640.
2. Amarenco P., Bogousslavsky J., Callahan A., et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006, 355:549-559.
3. Andrabi S.A., Kang H.C., Haince J.F., et al. Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death. Nat Med 2011, 17:692-699.
4. Andriessen T.M., Jacobs B., Vos P.E. Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 2010, 14:2381-2392.
5. Basu A., Krady J.K., O'Malley M., et al. The type 1 interleukin-1 receptor is essential for the efficient activation of microglia and the induction of multiple proinflammatory mediators in response to brain injury. J Neurosci 2002, 22:6071-6082.
6. Bendlin B.B., Ries M.L., Lazar M., et al. Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging. Neuroimage 2008, 42:503-514.
7. Bilsland J., Roy S., Xanthoudakis S., et al. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J Neurosci 2002, 22:2637-2649.
8. Block M.L., Hong J.S. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005, 76:77-98.
9. Block M.L., Zecca L., Hong J. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007, 8:57-69.
10. Bramlett H.M., Dietrich W.D. Quantitative structural changes in white and gray matter 1 year following traumatic brain injury in rats. Acta Neuropathol 2002, 103:607-614.
11. Bredesen D.E. Key note lecture: toward a mechanistic taxonomy for cell death programs. Stroke 2007, 38:652-660.
12. Bredesen D.E. Programmed cell death mechanisms in neurological disease. Curr Mol Med 2008, 8:173-186.
13. Bredesen D.E., Rao R.V., Mehlen P. Cell death in the nervous system. Nature 2006, 443:796-802.
14. Byrnes K.R., Loane D.J., Stoica B.A., et al. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J Neuroinflammation 2012, 9:43.
15. Cafferty W.B., Yang S.H., Duffy P.J., et al. Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci 2007, 27:2176-2185.
16. Camacho-Arroyo I., Perez-Palacios G., Pasapera A.M., et al. Intracellular progesterone receptors are differentially regulated by sex steroid hormones in the hypothalamus and the cerebral cortex of the rabbit. J Steroid Biochem Mol Biol 1994, 50:299-303.
17. Cande C., Vahsen N., Kouranti I., et al. AIF and cyclophilin A cooperate in apoptosis-associated chromatinolysis. Oncogene 2004, 23:1514-1521.
18. Cernak I., Stoica B., Byrnes K.R., et al. Role of the cell cycle in the pathobiology of central nervous system trauma. Cell Cycle 2005, 4:1286-1293.
19. Cernak I., Chang T., Ahmed F.A., et al. Pathophysiological response to experimental diffuse brain trauma differs as a function of developmental age. Dev Neurosci 2010, 32:442-453.
20. Chao C.C., Hu S., Ehrlich L., et al. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 1995, 9:355-365.
21. Chen J., Zhang C., Jiang H., et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab 2005, 25:281-290.
22. Chen S.F., Hung T.H., Chen C.C., et al. Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life Sci 2007, 81:288-298.
23. Chen G., Zhang S., Shi J., et al. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol 2009, 216:398-406.
24. Chen C.M., Yi H.Y., Yoon Y.H., et al. Alcohol use at time of injury and survival following traumatic brain injury: results from the National Trauma Data Bank. J Stud Alcohol Drugs 2012, 73:531-541.
25. Chiarugi A. "Simple but not simpler": toward a unified picture of energy requirements in cell death. FASEB J 2005, 19:1783-1788.
26. Clark R., Kochanek P., Watkins S., et al. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem 2000, 74:740-753.
27. Clark R.S., Nathaniel P.D., Zhang X., et al. boc-Aspartyl(OMe)-fluoromethylketone attenuates mitochondrial release of cytochrome c and delays brain tissue loss after traumatic brain injury in rats. J Cereb Blood Flow Metab 2006, 27:316-326.
28. Colton C.A. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol 2009, 4:399-418.
29. Colton C.A., Mott R.T., Sharpe H., et al. Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD. J Neuroinflammation 2006, 3:27.
30. Conde J.R., Streit W.J. Effect of aging on the microglial response to peripheral nerve injury. Neurobiol Aging 2006, 27:1451-1461.
31. Conde J.R., Streit W.J. Microglia in the aging brain. J Neuropathol Exp Neurol 2006, 65:199-203.
32. Conti A.C., Raghupathi R., Trojanowski J.Q., et al. Experimental brain injury induces regionally distinct apoptosis during the acute and delayed post-traumatic period. J Neurosci 1998, 18:5663-5672.
33. Csuka E., Morganti-Kossmann M.C., Lenzlinger P.M., et al. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6 TNF-alpha TGF-beta1 and blood-brain barrier function. J Neuroimmunol 1999, 101:211-221.
34. Cucchiara B., Kasner S.E. Use of statins in CNS disorders. J Neurol Sci 2001, 187:81-89.
35. Culmsee C., Zhu C., Landshamer S., et al. Apoptosis-inducing factor triggered by poly(ADP-Ribose) polymerase and bid mediates neuronal cell death after oxygen-glucose deprivation and focal cerebral ischemia. J Neurosci 2005, 25:10262-10272.
36. Cutler S.M., Cekic M., Miller D.M., et al. Progesterone improves acute recovery after traumatic brain injury in the aged rat. J Neurotrauma 2007, 24:1475-1486.
37. Daugas E., Nochy D., Ravagnan L., et al. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 2000, 476:118-123.
38. Davalos D., Grutzendler J., Yang G., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005, 8:752-758.
39. Declercq W., Takahashi N., Vandenabeele P. Dual face apoptotic machinery: from initiator of apoptosis to guardian of necroptosis. Immunity 2011, 35:493-495.
40. Delanty N., Vaughan C.J., Sheehy N. Statins and neuroprotection. Expert Opin Investig Drugs 2001, 10:1847-1853.
41. Di Giovanni S., Movsesyan V., Ahmed F., et al. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proc Natl Acad Sci U S A 2005, 102:8333-8338.
42. Djebaili M., Guo Q., Pettus E.H., et al. The neurosteroids progesterone and allopregnanolone reduce cell death gliosis and functional deficits after traumatic brain injury in rats. J Neurotrauma 2005, 22:106-118.
43. Eldadah B.A., Yakovlev A.G., Faden A.I. The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule cells. J Neurosci 1997, 17:6105-6113.
44. Eto M., Kozai T., Cosentino F., et al. Statin prevents tissue factor expression in human endothelial cells: role of Rho/Rho-kinase and Akt pathways. Circulation 2002, 105:1756-1759.
45. Faden A.I., Demediuk P., Panter S.S., et al. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989, 244:798-800.
46. Faden A.I., Fox G.B., Di X., et al. Neuroprotective and nootropic actions of a novel cyclized dipeptide after controlled cortical impact injury in mice. J Cereb Blood Flow Metab 2003, 23:355-363.
47. Faden A.I., Knoblach S.M., Cernak I., et al. Novel diketopiperazine enhances motor and cognitive recovery after traumatic brain injury in rats and shows neuroprotection in vitro and in vivo. J Cereb Blood Flow Metab 2003, 23:342-354.
48. Faden A.I., Knoblach S.M., Movsesyan V.A., et al. Novel small peptides with neuroprotective and nootropic properties. J Alzheimers Dis 2004, 6:S93-S97.
49. Faden A.I., Knoblach S.M., Movsesyan V.A., et al. Novel neuroprotective tripeptides and dipeptides. Ann N Y Acad Sci 2005, 1053:472-481.
50. Faden A.I., Movsesyan V.A., Knoblach S.M., et al. Neuroprotective effects of novel small peptides in vitro and after brain injury. Neuropharmacology 2005, 49:410-424.
51. Fan L., Young P.R., Barone F.C., et al. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res 1995, 30:125-130.
52. Fan L., Young P.R., Barone F.C., et al. Experimental brain injury induces differential expression of tumor necrosis factor-alpha mRNA in the CNS. Brain Res Mol Brain Res 1996, 36:287-291.
53. Faul M., Xu L., Wald M.M., et al. Traumatic Brain Injury in the United States: Emergency Department Visits Hospitalizations and Deaths 2002-2006. Centers for Disease Control and Prevention 2010, National Center for Injury Prevention and Control, Atlanta, GA.
54. Fee D.B., Swartz K.R., Joy K.M., et al. Effects of progesterone on experimental spinal cord injury. Brain Res 2007, 1137:146-152.
55. Finkelstein E.A., Corso P.S., Miller T.R. Incidence and Economic Burden of Injuries in the United States 2006, Oxford University Press, New York.
56. Fischer P.M., Gianella-Borradori A. Recent progress in the discovery and development of cyclin-dependent kinase inhibitors. Expert Opin Investig Drugs 2005, 14:457-477.
57. Fisher M., Feuerstein G., Howells D.W., et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009, 40:2244-2250.
58. Fox G.B., Levasseur R.A., Faden A.I. Behavioral responses of C57BL/6 FVB/N and 129/SvEMS mouse strains to traumatic brain injury: implications for gene targeting approaches to neurotrauma. J Neurotrauma 1999, 16:377-389.
59. Galbraith S. Head injuries in the elderly. Br Med J (Clin Res Ed) 1987, 294:325.
60. Galluzzi L., Vitale I., Abrams J.M., et al. Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 2012, 19:107-120.
61. Gentile N.T., Mcintosh T.K. Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury. Ann Emerg Med 1993, 22:1028-1034.
62. Gentleman S.M., Leclercq P.D., Moyes L., et al. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int 2004, 146:97-104.
63. Gibson C.L., Gray L.J., Bath P.M., et al. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008, 131:318-328.
64. Gilmer L.K., Roberts K.N., Scheff S.W. Efficacy of progesterone following a moderate unilateral cortical contusion injury. J Neurotrauma 2008, 25:593-602.
65. Godbout J.P., Chen J., Abraham J., et al. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 2005, 19:1329-1331.
66. Gonzalez Deniselle M.C., Lopez Costa J.J., Gonzalez S.L., et al. Basis of progesterone protection in spinal cord neurodegeneration. J Steroid Biochem Mol Biol 2002, 83:199-209.
67. Goodman J.C., Robertson C.S., Grossman R.G., et al. Elevation of tumor necrosis factor in head injury. J Neuroimmunol 1990, 30:213-217.
68. Goodman M.D., Makley A.T., Campion E.M., et al. Preinjury alcohol exposure attenuates the neuroinflammatory response to traumatic brain injury. J Surg Res 2013, 184:1053-1058.
69. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003, 3:23-35.
70. Gottron F.J., Ying H.S., Choi D.W. Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol Cell Neurosci 1997, 9:159-169.
71. Graham D.I., Adams J.H., Murray L.S., et al. Neuropathology of the vegetative state after head injury. Neuropsychol Rehabil 2005, 15:198-213.
72. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
73. Guan J., Mathai S., Harris P., et al. Peripheral administration of a novel diketopiperazine NNZ 2591 prevents brain injury and improves somatosensory-motor function following hypoxia-ischemia in adult rats. Neuropharmacology 2007, 53:749-762.
74. Hall E.D., Detloff M.R., Johnson K., et al. Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury. J Neurotrauma 2004, 21:9-20.
75. Hamby A.M., Suh S.W., Kauppinen T.M., et al. Use of a poly(ADP-ribose) polymerase inhibitor to suppress inflammation and neuronal death after cerebral ischemia-reperfusion. Stroke 2007, 38:632-636.
76. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007, 10:1387-1394.
77. Harrison J.K., Jiang Y., Chen S., et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A 1998, 95:10896-10901.
78. Haynes S.E., Hollopeter G., Yang G., et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat Neurosci 2006, 9:1512-1519.
79. He J., Hoffman S.W., Stein D.G. Allopregnanolone a progesterone metabolite enhances behavioral recovery and decreases neuronal loss after traumatic brain injury. Restor Neurol Neurosci 2004, 22:19-31.
80. He M., Liu W.G., Wen L., et al. Influence of acute ethanol intoxication on neuronal apoptosis and Bcl-2 protein expression after severe traumatic brain injury in rats. Chin J Traumatol 2013, 16:136-139.
81. Herrmann J.E., Imura T., Song B., et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 2008, 28:7231-7243.
82. Hilton G.D., Stoica B.A., Byrnes K.R., et al. Roscovitine reduces neuronal loss glial activation and neurologic deficits after brain trauma. J Cereb Blood Flow Metab 2008, 28:1845-1859.
83. Hoek R.M., Ruuls S.R., Murphy C.A., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 2000, 290:1768-1771.
84. Holmin S., Mathiesen T. Long-term intracerebral inflammatory response after experimental focal brain injury in rat. Neuroreport 1999, 10:1889-1891.
85. Jiang N., Chopp M., Stein D., et al. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 1996, 735:101-107.
86. Johnson V.E., Stewart J.E., Begbie F.D., et al. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain 2013, 136:28-42.
87. Joza N., Susin S.A., Daugas E., et al. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 2001, 410:549-554.
88. Kabadi S.V., Stoica B.A., Byrnes K.R., et al. Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma. J Cereb Blood Flow Metab 2012, 32:137-149.
89. Kabadi S.V., Stoica B.A., Hanscom M., et al. CR8 a selective and potent CDK inhibitor provides neuroprotection in experimental traumatic brain injury. Neurotherapeutics 2012, 9:405-421.
90. Kabadi S.V., Stoica B.A., Loane D.J., et al. Cyclin D1 gene ablation confers neuroprotection in traumatic brain injury. J Neurotrauma 2012, 29:813-827.
91. Kabadi S.V., Stoica B.A., Loane D.J., et al. CR8 a novel inhibitor of CDK limits microglial activation astrocytosis neuronal loss and neurologic dysfunction after experimental traumatic brain injury. J Cereb Blood Flow Metab 2014, 34:502-513.
92. Kauppinen T.M., Swanson R.A. Poly(ADP-ribose) polymerase-1 promotes microglial activation proliferation and matrix metalloproteinase-9-mediated neuron death. J Immunol 2005, 174:2288-2296.
93. Kauppinen T.M., Suh S.W., Berman A.E., et al. Inhibition of poly(ADP-ribose) polymerase suppresses inflammation and promotes recovery after ischemic injury. J Cereb Blood Flow Metab 2009, 29:820-829.
94. Kigerl K.A., Gensel J.C., Ankeny D.P., et al. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444.
95. Knoblach S.M., Faden A.I. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 1998, 153:143-151.
96. Knoblach S.M., Nikolaeva M., Huang X., et al. Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. J Neurotrauma 2002, 19:1155-1170.
97. Knoblach S.M., Alroy D.A., Nikolaeva M., et al. Caspase inhibitor z-DEVD-fmk attenuates calpain and necrotic cell death in vitro and after traumatic brain injury. J Cereb Blood Flow Metab 2004, 24:1119-1132.
98. Knoblach S.M., Huang X., Vangelderen J., et al. Selective caspase activation may contribute to neurological dysfunction after experimental spinal cord trauma. J Neurosci Res 2005, 80:369-380.
99. Kobori N., Clifton G.L., Dash P. Altered expression of novel genes in the cerebral cortex following experimental brain injury. Brain Res Mol Brain Res 2002, 104:148-158.
100. Krajewska M., You Z., Rong J., et al. Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS One 2011, 6:e24341.
101. Kremlev S.G., Palmer C. Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J Neuroimmunol 2005, 162:71-80.
102. Kroemer G., Galluzzi L., Vandenabeele P., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 2009, 16:3-11.
103. Kumar A., Stoica B.A., Sabirzhanov B., et al. Traumatic brain injury in aged animals increases lesion size and chronically alters microglial/macrophage classical and alternative activation states. Neurobiol Aging 2013, 34:1397-1411.
104. Lai Y., Hickey R.W., Chen Y., et al. Autophagy is increased after traumatic brain injury in mice and is partially inhibited by the antioxidant gamma-glutamylcysteinyl ethyl ester. J Cereb Blood Flow Metab 2008, 28:540-550.
105. Langlois J.A., Rutland-Brown W., Wald M.M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil 2006, 21:375-378.
106. Levin S. Apoptosis necrosis or oncosis: what is your diagnosis? A report from the Cell Death Nomenclature Committee of the Society of Toxicologic Pathologists. Toxicol Sci 1998, 41:155-156.
107. Levin S., Bucci T.J., Cohen S.M., et al. The nomenclature of cell death: recommendations of an ad hoc Committee of the Society of Toxicologic Pathologists. Toxicol Pathol 1999, 27:484-490.
108. Li P., Nijhawan D., Budihardjo I., et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91:479-489.
109. Li L.Y., Luo X., Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001, 412:95-99.
110. Liu C.L., Chen S., Dietrich D., et al. Changes in autophagy after traumatic brain injury. J Cereb Blood Flow Metab 2008, 28:674-683.
111. Loane D.J., Byrnes K.R. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7:366-377.
112. Loane D.J., Faden A.I. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. Trends Pharmacol Sci 2010, 31:596-604.
113. Lu D., Goussev A., Chen J., et al. Atorvastatin reduces neurological deficit and increases synaptogenesis angiogenesis and neuronal survival in rats subjected to traumatic brain injury. J Neurotrauma 2004, 21:21-32.
114. Lu K.T., Wang Y.W., Wo Y.Y., et al. Extracellular signal-regulated kinase-mediated IL-1-induced cortical neuron damage during traumatic brain injury. Neurosci Lett 2005, 386:40-45.
115. Lu K.T., Wang Y.W., Yang J.T., et al. Effect of interleukin-1 on traumatic brain injury-induced damage to hippocampal neurons. J Neurotrauma 2005, 22:885-895.
116. Lu D., Qu C., Goussev A., et al. Statins increase neurogenesis in the dentate gyrus reduce delayed neuronal death in the hippocampal CA3 region and improve spatial learning in rat after traumatic brain injury. J Neurotrauma 2007, 24:1132-1146.
117. Lucin K.M., Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little?. Neuron 2009, 64:110-122.
118. Luo X., Budihardjo I., Zou H., et al. Bid a Bcl2 interacting protein mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490.
119. Luo C.L., Li B.X., Li Q.Q., et al. Autophagy is involved in traumatic brain injury-induced cell death and contributes to functional outcome deficits in mice. NSC 2011, 184:54-63.
120. Lynch M.A. The multifaceted profile of activated microglia. Mol Neurobiol 2009, 40:139-156.
121. Maas A.I., Murray G., Henney H., et al. Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised placebo-controlled clinical trial. Lancet Neurol 2006, 5:38-45.
122. Maas A.I., Stocchetti N., Bullock R. Moderate and severe traumatic brain injury in adults. Lancet Neurol 2008, 7:728-741.
123. Maas A.I., Roozenbeek B., Manley G.T. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 2010, 7:115-126.
124. Maeda T., Kawane T., Horiuchi N. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation. Endocrinology 2003, 144:681-692.
125. Magnuson J., Leonessa F., Ling G.S. Neuropathology of explosive blast traumatic brain injury. Curr Neurol Neurosci Rep 2012, 12:570-579.
126. Majno G., Joris I. Apoptosis oncosis and necrosis. An overview of cell death. Am J Pathol 1995, 146:3-15.
127. Majno G., Joris I. Commentary: on the misuse of the term "necrosis": a step in the right direction. Toxicol Pathol 1999, 27:494.
128. Mantovani A., Sica A., Sozzani S., et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
129. Margulies S., Hicks R. Combination therapies for traumatic brain injury: prospective considerations. J Neurotrauma 2009, 26:925-939.
130. Maxwell W.L., Mackinnon M.A., Smith D.H., et al. Thalamic nuclei after human blunt head injury. J Neuropathol Exp Neurol 2006, 65:478-488.
131. Mazzeo A.T., Alves O.L., Gilman C.B., et al. Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study. Acta Neurochir (Wien) 2008, 150:1019-1031. discussion 1031.
132. Mazzeo A.T., Beat A., Singh A., et al. The role of mitochondrial transition pore and its modulation in traumatic brain injury and delayed neurodegeneration after TBI. Exp Neurol 2009, 218:363-370.
133. Mbye L.H., Singh I.N., Sullivan P.G., et al. Attenuation of acute mitochondrial dysfunction after traumatic brain injury in mice by NIM811 a non-immunosuppressive cyclosporin A analog. Exp Neurol 2008, 209:243-253.
134. Mbye L.H., Singh I.N., Carrico K.M., et al. Comparative neuroprotective effects of cyclosporin A and NIM811 a nonimmunosuppressive cyclosporin A analog following traumatic brain injury. J Cereb Blood Flow Metab 2009, 29:87-97.
135. Meijer L., Borgne A., Mulner O., et al. Biochemical and cellular effects of roscovitine a potent and selective inhibitor of the cyclin-dependent kinases cdc2 cdk2 and cdk5. Eur J Biochem 1997, 243:527-536.
136. Moorthy K., Sharma D., Basir S.F., et al. Administration of estradiol and progesterone modulate the activities of antioxidant enzyme and aminotransferases in naturally menopausal rats. Exp Gerontol 2005, 40:295-302.
137. Morganti-Kossmann M.C., Hans V.H., Lenzlinger P.M., et al. TGF-beta is elevated in the CSF of patients with severe traumatic brain injuries and parallels blood-brain barrier function. J Neurotrauma 1999, 16:617-628.
138. Morganti-Kossmann M.C., Rancan M., Otto V.I., et al. Role of cerebral inflammation after traumatic brain injury: a revisited concept. Shock 2001, 16:165-177.
139. Morganti-Kossmann M.C., Satgunaseelan L., Bye N., et al. Modulation of immune response by head injury. Injury 2007, 38:1392-1400.
140. Moubarak R.S., Yuste V.J., Artus C., et al. Sequential activation of PARP-1 calpains and Bax is essential in AIF-mediated programmed necrosis. Mol Cell Biol 2007, 27:4844-4862.
141. Myer D.J., Gurkoff G.G., Lee S.M., et al. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006, 129:2761-2772.
142. Narayan R.K., Michel M.E., Ansell B., et al. Clinical trials in head injury. J Neurotrauma 2002, 19:503-557.
143. Natale J.E., Ahmed F., Cernak I., et al. Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. J Neurotrauma 2003, 20:907-927.
144. Nimmerjahn A., Kirchhoff F., Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005, 308:1314-1318.
145. O'Connor C.A., Cernak I., Johnson F., et al. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Exp Neurol 2007, 205:145-153.
146. Okonkwo D.O., Povlishock J.T. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J Cereb Blood Flow Metab 1999, 19:443-451.
147. Okonkwo D.O., Buki A., Siman R., et al. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 1999, 10:353-358.
148. Osato K., Sato Y., Ochiishi T., et al. Apoptosis-inducing factor deficiency decreases the proliferation rate and protects the subventricular zone against ionizing radiation. Cell Death Dis 2010, 1:e84.
149. Padmanabhan J., Park D.S., Greene L.A., et al. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J Neurosci 1999, 19:8747-8756.
150. Pan D.S., Liu W.G., Yang X.F., et al. Inhibitory effect of progesterone on inflammatory factors after experimental traumatic brain injury. Biomed Environ Sci 2007, 20:432-438.
151. Patel A.D., Gerzanich V., Geng Z., et al. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J Neuropathol Exp Neurol 2010, 69:1177-1190.
152. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
153. Pekny M., Johansson C.B., Eliasson C., et al. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 1999, 145:503-514.
154. Pennings J.L., Bachulis B.L., Simons C.T., et al. Survival after severe brain injury in the aged. Arch Surg 1993, 128:787-793. discussion 793-794.
155. Pettus E.H., Wright D.W., Stein D.G., et al. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 2005, 1049:112-119.
156. Piao C.S., Loane D.J., Stoica B.A., et al. Combined inhibition of cell death induced by apoptosis inducing factor and caspases provides additive neuroprotection in experimental traumatic brain injury. Neurobiol Dis 2012, 46:745-758.
157. Pinteaux E., Parker L.C., Rothwell N.J., et al. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 2002, 83:754-763.
158. Pitts L.H., Ross A., Chase G.A., et al. Treatment with thyrotropin-releasing hormone (TRH) in patients with traumatic spinal cord injuries. J Neurotrauma 1995, 12:235-243.
159. Ponomarev E.D., Maresz K., Tan Y., et al. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 2007, 27:10714-10721.
160. Popa-Wagner A., Carmichael S.T., Kokaia Z., et al. The response of the aged brain to stroke: too much too soon?. Curr Neurovasc Res 2007, 4:216-227.
161. Qiu J., Whalen M.J., Lowenstein P., et al. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J Neurosci 2002, 22:3504-3511.
162. Qu C., Lu D., Goussev A., et al. Effect of atorvastatin on spatial memory neuronal survival and vascular density in female rats after traumatic brain injury. J Neurosurg 2005, 103:695-701.
163. Raghavendra Rao V.L., Dhodda V.K., Song G., et al. Traumatic brain injury-induced acute gene expression changes in rat cerebral cortex identified by GeneChip analysis. J Neurosci Res 2003, 71:208-219.
164. Ramlackhansingh A.F., Brooks D.J., Greenwood R.J., et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 2011, 70:374-383.
165. Rink A., Fung K.M., Trojanowski J.Q., et al. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am J Pathol 1995, 147:1575-1583.
166. Roof R.L., Hall E.D. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. J Neurotrauma 2000, 17:367-388.
167. Roof R.L., Zhang Q., Glasier M.M., et al. Gender-specific impairment on Morris water maze task after entorhinal cortex lesion. Behav Brain Res 1993, 57:47-51.
168. Roof R.L., Duvdevani R., Braswell L., et al. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp Neurol 1994, 129:64-69.
169. Roof R.L., Duvdevani R., Heyburn J.W., et al. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol 1996, 138:246-251.
170. Roof R.L., Hoffman S.W., Stein D.G. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol 1997, 31:1-11.
171. Ross S.A., Halliday M.I., Campbell G.C., et al. The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg 1994, 8:419-425.
172. Rothwell N. Interleukin-1 and neuronal injury: mechanisms modification and therapeutic potential. Brain Behav Immun 2003, 17:152-157.
173. Saatman K.E., Duhaime A.C., Bullock R., et al. Classification of traumatic brain injury for targeted therapies. J Neurotrauma 2008, 25:719-738.
174. Sadasivan S., Dunn W.A., Hayes R.L., et al. Changes in autophagy proteins in a rat model of controlled cortical impact induced brain injury. Biochem Biophys Res Commun 2008, 373:478-481.
175. Sandhir R., Onyszchuk G., Berman N.E. Exacerbated glial response in the aged mouse hippocampus following controlled cortical impact injury. Exp Neurol 2008, 213:372-380.
176. Schafer D.P., Lehrman E.K., Kautzman A.G., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
177. Scherbel U., Raghupathi R., Nakamura M.S., et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc Natl Acad Sci U S A 1999, 96:8721-8726.
178. Schousboe A., Waagepetersen H.S. Role of astrocytes in glutamate homeostasis: implications for excitotoxicity. Neurotox Res 2005, 8:221-225.
179. Schouten J.W. Neuroprotection in traumatic brain injury: a complex struggle against the biology of nature. Curr Opin Crit Care 2007, 13:134-142.
180. Shohami E., Novikov M., Bass R., et al. Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue. J Cereb Blood Flow Metab 1994, 14:615-619.
181. Shohami E., Gallily R., Mechoulam R., et al. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. J Neuroimmunol 1997, 72:169-177.
182. Simard J.M., Woo S.K., Bhatta S., et al. Drugs acting on SUR1 to treat CNS ischemia and trauma. Curr Opin Pharmacol 2008, 8:42-49.
183. Simard J.M., Geng Z., Woo S.K., et al. Glibenclamide reduces inflammation vasogenic edema and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2009, 29:317-330.
184. Simard J.M., Kilbourne M., Tsymbalyuk O., et al. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J Neurotrauma 2009, 26:2257-2267.
185. Simard J.M., Woo S.K., Schwartzbauer G.T., et al. Sulfonylurea receptor 1 in central nervous system injury: a focused review. J Cereb Blood Flow Metab 2012, 32:1699-1717.
186. Slemmer J.E., Zhu C., Landshamer S., et al. Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am J Pathol 2008, 173:1795-1805.
187. Smith S.S. Progesterone administration attenuates excitatory amino acid responses of cerebellar Purkinje cells. Neuroscience 1991, 42:309-320.
188. Smith D.H., Chen X.H., Pierce J.E., et al. Progressive atrophy and neuron death for one year following brain trauma in the rat. J Neurotrauma 1997, 14:715-727.
189. Smith D.H., Chen X.H., Xu B.N., et al. Characterization of diffuse axonal pathology and selective hippocampal damage following inertial brain trauma in the pig. J Neuropathol Exp Neurol 1997, 56:822-834.
190. Sperandio S., De Belle I., Bredesen D.E. An alternative nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A 2000, 97:14376-14381.
191. STAIR (Stroke Therapy Academic Industry Roundtable) Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999, 30:2752-2758.
192. Statler K.D., Alexander H., Vagni V., et al. Comparison of seven anesthetic agents on outcome after experimental traumatic brain injury in adult male rats. J Neurotrauma 2006, 23:97-108.
193. Stein D.G., Wright D.W. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs 2010, 19:847-857.
194. Stoica B.A., Faden A.I. Programmed neuronal cell death mechanisms in CNS injury. Acute Neuronal Injury: The Role of Excitotoxic Programmed Cell Death Mechanisms 2010, 169-199. Springer. D.G. Fujikawa (Ed.).
195. Stoica B.A., Faden A.I. Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics 2010, 7:3-12.
196. Stoica B., Byrnes K., Faden A.I. Multifunctional drug treatment in neurotrauma. Neurotherapeutics 2009, 6:14-27.
197. Stoica B.A., Loane D.J., Zhao Z., et al. PARP-1 inhibition attenuates neuronal loss microglia activation and neurological deficits after traumatic brain injury. J Neurotrauma 2014, 31:758-772.
198. Stover J.F., Schoning B., Beyer T.F., et al. Temporal profile of cerebrospinal fluid glutamate interleukin-6 and tumor necrosis factor-alpha in relation to brain edema and contusion following controlled cortical impact injury in rats. Neurosci Lett 2000, 288:25-28.
199. Sullivan P.G., Bruce-Keller A.J., Rabchevsky A.G., et al. Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J Neurosci 1999, 19:6248-6256.
200. Sullivan P.G., Thompson M.B., Scheff S.W. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 1999, 160:226-234.
201. Sullivan P.G., Rabchevsky A.G., Hicks R.R., et al. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 2000, 101:289-295.
202. Sullivan P.G., Thompson M., Scheff S.W. Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp Neurol 2000, 161:631-637.
203. Sullivan P.G., Keller J.N., Bussen W.L., et al. Cytochrome c release and caspase activation after traumatic brain injury. Brain Res 2002, 949:88-96.
204. Sullivan S., Friess S.H., Ralston J., et al. Behavioral deficits and axonal injury persistence after rotational head injury are direction dependent. J Neurotrauma 2013, 30:538-545.
205. Susin S.A., Lorenzo H.K., Zamzami N., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999, 397:441-446.
206. Suzuki S., Chuang L.F., Doi R.H., et al. Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence. Int Immunopharmacol 2001, 1:1733-1742.
207. Szabo I., Zoratti M. The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. J Biol Chem 1991, 266:3376-3379.
208. Tang M., Alexander H., Clark R.S., et al. Minocycline reduces neuronal death and attenuates microglial response after pediatric asphyxial cardiac arrest. J Cereb Blood Flow Metab 2010, 30:119-129.
209. Tapia-Perez J.H., Sanchez-Aguilar M., Torres-Corzo J.G., et al. Effect of rosuvastatin on amnesia and disorientation after traumatic brain injury (NCT003229758). J Neurotrauma 2008, 25:1011-1017.
210. Tehranian R., Andell-Jonsson S., Beni S.M., et al. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. J Neurotrauma 2002, 19:939-951.
211. Toulmond S., Rothwell N.J. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Brain Res 1995, 671:261-266.
212. Tremblay M.E., Stevens B., Sierra A., et al. The role of microglia in the healthy brain. J Neurosci 2011, 31:16064-16069.
213. Tseng M.Y., Czosnyka M., Richards H., et al. Effects of acute treatment with pravastatin on cerebral vasospasm autoregulation and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005, 36:1627-1632.
214. Tyor W.R., Avgeropoulos N., Ohlandt G., et al. Treatment of spinal cord impact injury in the rat with transforming growth factor-beta. J Neurol Sci 2002, 200:33-41.
215. Van Loo G., Saelens X., Van Gurp M., et al. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 2002, 9:1031-1042.
216. Vandenabeele P., Galluzzi L., Vanden Berghe T., et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol 2010, 11:700-714.
217. Verdaguer E., Jimenez A., Canudas A.M., et al. Inhibition of cell cycle pathway by flavopiridol promotes survival of cerebellar granule cells after an excitotoxic treatment. J Pharmacol Exp Ther 2004, 308:609-616.
218. Vespa P., Bergsneider M., Hattori N., et al. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab 2005, 25:763-774.
219. Vink R., Nimmo A.J. Multifunctional drugs for head injury. Neurotherapeutics 2009, 6:28-42.
220. Vink R., Van Den Heuvel C. Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury. Neurotherapeutics 2010, 7:74-80.
221. Volbracht C., Leist M., Kolb S.A., et al. Apoptosis in caspase-inhibited neurons. Mol Med 2001, 7:36-48.
222. Wang H., Yu S.W., Koh D.W., et al. Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci 2004, 24:10963-10973.
223. Wang H., Lynch J.R., Song P., et al. Simvastatin and atorvastatin improve behavioral outcome reduce hippocampal degeneration and improve cerebral blood flow after experimental traumatic brain injury. Exp Neurol 2007, 206:59-69.
224. Wang Y., Dawson V.L., Dawson T.M. Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos. Exp Neurol 2009, 218:193-202.
225. Wang J.Y., Xia Q., Chu K.T., et al. Severe global cerebral ischemia-induced programmed necrosis of hippocampal CA1 neurons in rat is prevented by 3-methyladenine: a widely used inhibitor of autophagy. J Neuropathol Exp Neurol 2011, 70:314-322.
226. Wang Y., Kim N.S., Haince J.F., et al. Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos). Science Signal 2011, 4:ra20.
227. Wang Z., Shi X.Y., Yin J., et al. Role of autophagy in early brain injury after experimental subarachnoid hemorrhage. J Mol Neurosci 2012, 46:192-202.
228. Wible E.F., Laskowitz D.T. Statins in traumatic brain injury. Neurotherapeutics 2010, 7:62-73.
229. Wilhelmsson U., Li L., Pekna M., et al. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci 2004, 24:5016-5021.
230. Winter C.D., Iannotti F., Pringle A.K., et al. A microdialysis method for the recovery of IL-1beta IL-6 and nerve growth factor from human brain in vivo. J Neurosci Methods 2002, 119:45-50.
231. Woodroofe M.N., Sarna G.S., Wadhwa M., et al. Detection of interleukin-1 and interleukin-6 in adult rat brain following mechanical injury by in vivo microdialysis: evidence of a role for microglia in cytokine production. J Neuroimmunol 1991, 33:227-236.
232. Wright D.W., Kellermann A.L., Hertzberg V.S., et al. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 2007, 49:391-402. 402 e1-2.
233. Wu H., Lu D., Jiang H., et al. Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury. J Neurosurg 2008, 109:691-698.
234. Wu H., Lu D., Jiang H., et al. Simvastatin-mediated upregulation of VEGF and BDNF activation of the PI3K/Akt pathway and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 2008, 25:130-139.
235. Xiao G., Wei J., Yan W., et al. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 2008, 12:R61.
236. Xiong Y., Gu Q., Peterson P.L., et al. Mitochondrial dysfunction and calcium perturbation induced by traumatic brain injury. J Neurotrauma 1997, 14:23-34.
237. Yakovlev A.G., Knoblach S.M., Fan L., et al. Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury. J Neurosci 1997, 17:7415-7424.
238. Yakovlev A.G., Ota K., Wang G., et al. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci 2001, 21:7439-7446.
239. Yan W., Zhang H., Bai X., et al. Autophagy activation is involved in neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats. Brain Res 2011, 1402:109-121.
240. You Z., Savitz S.I., Yang J., et al. Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice. J Cereb Blood Flow Metab 2008, 28:1564-1573.
241. Yao X.L., Liu J., Lee E., et al. Progesterone differentially regulates pro- and anti-apoptotic gene expression in cerebral cortex following traumatic brain injury in rats. J Neurotrauma 2005, 22:656-668.
242. Yu S.W., Wang H., Poitras M.F., et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 2002, 297:259-263.
243. Yu S.W., Wang Y., Frydenlund D.S., et al. Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release. ASN Neuro 2009, 1:275-281.
244. Zacco A., Togo J., Spence K., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci 2003, 23:11104-11111.
245. Zhang X., Chen J., Graham S.H., et al. Intranuclear localization of apoptosis-inducing factor (AIF) and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J Neurochem 2002, 82:181-191.
246. Zhang D., Hu X., Qian L., et al. Astrogliosis in CNS pathologies: is there a role for microglia?. Mol Neurobiol 2010, 41:232-241.
247. Zhao Z., Alam S., Oppenheim R.W., et al. Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy. Exp Neurol 2004, 190:356-372.
248. Zhu C., Qiu L., Wang X., et al. Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain. J Neurochem 2003, 86:306-317.
249. Zhu C., Wang X., Deinum J., et al. Cyclophilin A participates in the nuclear translocation of apoptosis-inducing factor in neurons after cerebral hypoxia-ischemia. J Exp Med 2007, 204:1741-1748.
250. Zhu C., Wang X., Huang Z., et al. Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ 2007, 14:775-784.